Your browser doesn't support javascript.
loading
Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
van de Logt, Anne-Els; Dahan, Karine; Rousseau, Alexandra; van der Molen, Renate; Debiec, Hanna; Ronco, Pierre; Wetzels, Jack.
Afiliação
  • van de Logt AE; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Nephrology, Nijmegen, The Netherlands. Electronic address: Anne-Els.vandeLogt@radboudumc.nl.
  • Dahan K; AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, F-75020, Paris, France.
  • Rousseau A; Unité de Recherche Clinique de l'Est Parisien (URC-Est) Hôpitaux Universitaires Paris Est (AP-HP) Hôpital Saint-Antoine, F-75012, Paris, France.
  • van der Molen R; Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Debiec H; Sorbonne Universités, UPMC Univ Paris 06, F-75005, Paris, France; INSERM, UMR_S 1155, F-75020, Paris, France.
  • Ronco P; AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, F-75020, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, F-75005, Paris, France; INSERM, UMR_S 1155, F-75020, Paris, France.
  • Wetzels J; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Nephrology, Nijmegen, The Netherlands.
Kidney Int ; 93(4): 1016-1017, 2018 04.
Article em En | MEDLINE | ID: mdl-29571438
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Glomerulonefrite Membranosa / Autoimunidade / Ciclofosfamida / Receptores da Fosfolipase A2 / Rituximab / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Glomerulonefrite Membranosa / Autoimunidade / Ciclofosfamida / Receptores da Fosfolipase A2 / Rituximab / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article